Caribou Biosciences, Inc. Preferred Shares: Authorized and Outstanding
The company's filed XBRL preferred stock facts (us-gaap Preferred*), one row per period end, newest first. Values are as filed.
- 2023-09-30: Preferred Stock, Value, Issued $0.00; Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 10.00M shares.
- 2023-06-30: Preferred Stock, Value, Issued $0.00; Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 10.00M shares.
- 2023-03-31: Preferred Stock, Value, Issued $0.00; Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 10.00M shares.
- 2022-12-31: Preferred Stock, Value, Issued $0.00; Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 10.00M shares.
| Period end | Preferred Stock, Value, Issued | Preferred Stock, Par or Stated Value Per Share | Preferred Stock, No Par Value | Preferred Stock, Shares Authorized | Preferred Stock, Shares Issued | Preferred Stock, Shares Outstanding | Preferred Stock, Liquidation Preference, Value |
|---|---|---|---|---|---|---|---|
| 2023-09-30 | $0.00 10-Q · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | 10.00M shares 10-Q · filed 2023-11-07 | 0.00 shares 10-Q · filed 2023-11-07 | 0.00 shares 10-Q · filed 2023-11-07 | ||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | 10.00M shares 10-Q · filed 2023-08-08 | 0.00 shares 10-Q · filed 2023-08-08 | 0.00 shares 10-Q · filed 2023-08-08 | ||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 10-Q · filed 2023-05-09 | 10.00M shares 10-Q · filed 2023-05-09 | 0.00 shares 10-Q · filed 2023-05-09 | 0.00 shares 10-Q · filed 2023-05-09 | ||
| 2022-12-31 | $0.00 10-Q · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | 10.00M shares 10-Q · filed 2023-11-07 | 0.00 shares 10-Q · filed 2023-11-07 | 0.00 shares 10-Q · filed 2023-11-07 | ||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | 10.00M shares 10-Q · filed 2022-11-08 | 0.00 shares 10-Q · filed 2022-11-08 | 0.00 shares 10-Q · filed 2022-11-08 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | 10.00M shares 10-Q · filed 2022-08-09 | 0.00 shares 10-Q · filed 2022-08-09 | 0.00 shares 10-Q · filed 2022-08-09 | ||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-09 | $0.00 10-Q · filed 2022-05-09 | 10.00M shares 10-Q · filed 2022-05-09 | 0.00 shares 10-Q · filed 2022-05-09 | 0.00 shares 10-Q · filed 2022-05-09 | ||
| 2021-12-31 | $0.00 10-K · filed 2023-03-09 | $0.00 10-K · filed 2023-03-09 | $0.00 10-Q · filed 2022-08-09 | 10.00M shares 10-K · filed 2023-03-09 | 0.00 shares 10-K · filed 2023-03-09 | 0.00 shares 10-K · filed 2023-03-09 | |
| 2021-09-30 | 0.00 shares 10-Q · filed 2021-11-09 | 0.00 shares 10-Q · filed 2021-11-09 | |||||
| 2021-07-27 | 10.00M shares 10-Q · filed 2021-11-09 | ||||||
| 2020-12-31 | $0.00 10-K · filed 2022-03-21 | $0.00 10-K · filed 2022-03-21 | 0.00 shares 10-K · filed 2022-03-21 | 0.00 shares 10-K · filed 2022-03-21 | 0.00 shares 10-K · filed 2022-03-21 | $41.62M 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |